Literature DB >> 12419469

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients.

Cristina Cecchi1, Claudia Fiorillo, Sandro Sorbi, Stefania Latorraca, Benedetta Nacmias, Silvia Bagnoli, Paolo Nassi, Gianfranco Liguri.   

Abstract

We have measured the levels of typical end products of the processes of lipid peroxidation, protein oxidation, and total antioxidant capacity (TAC) in skin fibroblasts and lymphoblasts taken from patients with familial Alzheimer's disease (FAD), sporadic Alzheimer's disease (AD), and age-matched healthy controls. Compared to controls, the fibroblasts and lymphoblasts carrying amyloid precursor protein (APP) and presenilin-1 (PS-1) gene mutations showed a clear increase in lipoperoxidation products, malondialdehyde (MDA), and 4-hydroxynonenal (4-HNE). In contrast, the antioxidant defenses of cells from FAD patients were lower than those from normal subjects. Lipoperoxidation and antioxidant capacity in lymphoblasts from patients affected by sporadic AD were virtually indistinguishable from the basal values of normal controls. An oxidative attack on protein gave rise to greater protein carbonyl content in FAD patients than in age-matched controls. Furthermore, ADP ribosylation levels of poly(ADP-ribose) polymerase (PARP) nuclear substrates were significantly raised, whereas the PARP content did not differ significantly between fibroblasts carrying gene mutations and control cells. These results indicate that peripheral cells carrying APP and PS-1 gene mutations show altered levels of oxidative markers even though they are not directly involved in the neurodegenerative process of AD. These results support the hypothesis that oxidative damage to lipid, protein, and DNA is an important early event in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419469     DOI: 10.1016/s0891-5849(02)01049-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  37 in total

1.  PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; George Perry; Jesús Avila; Vega García-Escudero
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

2.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Xinglong Wang; Bo Su; Hisashi Fujioka; Xiongwei Zhu
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

Review 3.  Interactions of Mitochondria/Metabolism and Calcium Regulation in Alzheimer's Disease: A Calcinist Point of View.

Authors:  Gary E Gibson; Ankita Thakkar
Journal:  Neurochem Res       Date:  2017-02-08       Impact factor: 3.996

Review 4.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

Review 5.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 6.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 7.  Reactive oxygen species-activated nanomaterials as theranostic agents.

Authors:  Kye S Kim; Dongwon Lee; Chul Gyu Song; Peter M Kang
Journal:  Nanomedicine (Lond)       Date:  2015-09-02       Impact factor: 5.307

Review 8.  Oxidative stress and transcriptional regulation in Alzheimer disease.

Authors:  Qingli Shi; Gary E Gibson
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

9.  Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

Authors:  Jinfang Wu; Md Riyaz Basha; Brian Brock; David P Cox; Fernando Cardozo-Pelaez; Christopher A McPherson; Jean Harry; Deborah C Rice; Bryan Maloney; Demao Chen; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

10.  Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts.

Authors:  Graziella Mendonsa; Justyna Dobrowolska; Angela Lin; Pooja Vijairania; Y-J I Jong; Nancy L Baenziger
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.